0635 Validation of a clinical scale for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium-V45IS1 0635 Validation of a clinical scale for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium-V45IS1 Download 0634 Symptoms of insomnia and depression among individuals with Multiple Sclerosis before and during the COVID-19 – results from a prospective longitudinal study-V45IS1 0636 Objective sleep as a predictor of cognitive decline among non-demented elderly: preliminary results from the Cretan Aging Cohort-V45IS1
